价格

PSMA CAR-T

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ANTI-PSMA SINGLE-CHAIN ANTIBODY, CHIMERIC ANTIGEN RECEPTOR ASSOCIATED THEREWITH AND USE THEREOF
EP 4573130 A4申请人: BEIJING MEIKANG GENO IMMUNE BIOTECHNOLOGY CO LTD优先权: 2022
CN
EP
US
WO
4 件公开
Chimeric antigen receptors that bind to prostate specific membrane antigen
- US 12428492 B2
  申请人: UNIV FREIBURG ALBERT LUDWIGS优先权: 2019
  CN
  EP
  US
  4 件公开
- EP 3587454 A1
  申请人: UNIV FREIBURG ALBERT LUDWIGS优先权: 2018
  CN
  EP
  3 件公开
Prostate-specific membrane antigen cars and methods of use thereof
US 10780120 B2申请人: UNIV PENNSYLVANIA优先权: 2018
CN
US
3 件公开
Compositions and methods comprising prostate stem cell antigen (PSCA) chimeric antigen receptors (CARs)
US 11766453 B2申请人: UNIV PENNSYLVANIA优先权: 2019
CN
US
2 件公开
ANTI-PSMA ANTIBODIES AND CAR-T STRUCTURES
US 2024226162 A9申请人: TENEOBIO INC优先权: 2021
CN
US
2 件公开
一种基于OCTS技术的前列腺癌CAR-T治疗载体及其构建方法和应用
CN 107164410 B申请人: 上海优卡迪生物医药科技有限公司优先权: 2017
CN
一种靶向表达PSMA表面抗原的细胞的嵌合抗原受体
CN 108640999 B申请人: 广东万海细胞生物科技有限公司优先权: 2018
CN
Double chimeric antigen receptor gene-modified immune cell based on CD19 and PSMA and application thereof
CN 109468284 A申请人: BEIJING MEIKANG JIMIAN BIOTECHNOLOGY CO LTD优先权: 2018
CN
Antibody targeting PSMA protein, chimeric antigen receptor, drug and application
CN 114075291 A申请人: THE FIRST AFFILIATED HOSPITAL OF NAVAL MEDICAL UNIV OF CHINESE PEOPLES LIBERATION ARMY优先权: 2020
CN
Method for improving durability of CAR-T cell population
CN 115612673 A申请人: KARUIJI BEIJING LIFE TECH CO LTD优先权: 2022
CN

药物

PSMA CAR-T

专利

Chimeric antigen receptors that bind to prostate specific membrane antigen